Dr. Jitendra Kumar Pehalajani

Dr Jitendra Kumar Pehalajani is a Medical Oncologist in Jaipur with 21 years of clinical experience.

He currently practises as a Consultant at HCG Cancer Centre in Mansarovar. His clinical focus is the administration of highly advanced systemic therapies for complex solid and hematological malignancies.

He possesses highly specialized expertise in managing advanced breast and colorectal cancers, severe leukemias, and holds a dedicated clinical interest in managing Teenage and Young Adult (TYA) malignancies.

Prior to his current consultancy role at HCG, he served as a Consultant at Shalby Hospital in Jaipur.

Dr Pehalajani is a highly prominent clinical researcher with publications in some of the world's most elite medical journals. In 2024, he co-authored critical research regarding Olanzapine for chemotherapy-induced nausea control in 'The Lancet Oncology'.

He has also published major clinical outcome audits on CDK 4/6 inhibitors for metastatic breast cancer (JCRT, 2021), and specialized research on managing Chronic Myeloid Leukemia (CML) in the elderly (Indian Journal of Hematology & Blood Transfusion, 2020).

Demonstrating his clinical excellence during his training, he was recognized as the 1st Runner-Up for the prestigious Torrent Young Scholar Award (TYSA) at the ISMPOCON national conference in 2018.

In his clinical practice, he routinely integrates precision molecular medicine, targeted biological therapies, and modern immunotherapy protocols into complex, multidisciplinary cancer treatment plans.

He also holds extensive expertise in advanced hematology, focusing heavily on blood component therapy and transfusion protocols for bone marrow failure syndromes.

Specialty Areas and Treatments

Dr Jitendra Kumar Pehalajani provides comprehensive systemic cancer therapies, utilizing the most recent global evidence-based treatment algorithms.

Solid Tumor Oncology and Immunotherapy

Dr Pehalajani utilizes precision medicine to target cancer cells at the molecular level:

• Targeted Molecular Therapy (e.g., CDK4/6 Inhibitors for Breast Cancer)
• Immunotherapy and Checkpoint Inhibitors
• Systemic Treatment of Lung, Colorectal, and Genitourinary Malignancies
• Neoadjuvant and Adjuvant Systemic Chemotherapy

Hematological and Young Adult Oncology

He manages both blood-based cancers and uniquely challenging demographic malignancies:

• Management of Leukemias (including CML in elderly populations) and Lymphomas
• Management of Teenage and Young Adult (TYA) Cancers
• Advanced Transfusion Medicine for Bone Marrow Failure Syndromes
• Oncological Palliative Care and Chemotherapy Symptom Management

Education and Qualifications

• MBBS — Dr Vaishampayan Memorial Government Medical College, Solapur (2005)
• MD in General Medicine — Pandit Bhagwat Dayal Sharma University of Health Sciences, Rohtak (2015)
• DM in Oncology — Kidwai Cancer Institute, Bengaluru (2019)

Professional Experience

Dr Jitendra Kumar Pehalajani currently practises at the following facility:

• Consultant Medical Oncologist, HCG Cancer Centre in Mansarovar

Book an Appointment with Dr Jitendra Kumar Pehalajani

To book an appointment with Dr Jitendra Kumar Pehalajani or to check OPD timings and consultation details at HCG Cancer Centre in Mansarovar in Jaipur, connect with the HexaHealth team for assistance.